Skip to main content

Christina Leigh Stallings

NIH Rank #1323
  • R01 Holder
  • Top 10% Funded
  • Multi-Institutional
  • Early Career
  • Diverse Portfolio

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 8858454Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Microbiology & Immunology
  • Internal Medicine

NIH Funding · FY2026

Linked Award Amount
$3.2M
Full award amounts, FY2026
Award Records
6
Records listing this PI
Award-Linked Rank
#1,323
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Christina Leigh Stallings. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2026 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2026 award records by amount

NIH award records listing Christina Leigh Stallings as a PI. Multi-PI records show the full award amount for context.

  • 5R01AI184666-03R01
    Type I IFN-dependent and independent contributions to the outcomes of early innate immune cell interactions during HIV/TB co-infection
    $872.1K
    award amount
  • 5R01AI181316-03R01
    Development of 1,2,4-Triazolyl Compounds and their derivatives as a New Treatment for Tuberculosis
    $745.5K
    award amount
  • 1R01HL182099-01A1R01
    Investigating the roles for sphingolipid biosynthesis during lung infection
    $680.4K
    award amount
  • 5R01AI179024-04R01
    Targeting NETosis for the Treatment of Tuberculosis
    $628.3K
    award amount
  • 1R21AI197485-01R21
    Dissecting the Contribution of Neutrophils to Diabetes/Tuberculosis Comorbidity
    $259.1K
    award amount
  • 1R13AI200297-01R13
    2026 Microbial Stress Response Gordon Research Conference and Gordon Research Seminar
    $14K
    award amount

Award organizations

Organizations that administered FY2026 awards listing Christina Leigh Stallings as a PI.

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Washington University in St. Louis
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #4148
  6. 2024
    Entered Top 25% Nationally
    Ranked #4148
  7. 2025
    Multi-Institutional Research
    Awards at 3 institutions
  8. 2025
    R01 Grant Holder
  9. 2026
    $5M Cumulative Funding
  10. 2026
    Entered Top 10% Nationally
    Ranked #1323